BioPorto A/S (CPH:BIOPOR)
0.9410
+0.0230 (2.51%)
At close: Mar 5, 2026
BioPorto Market Cap
BioPorto has a market cap or net worth of 465.89 million as of March 5, 2026. Its market cap has decreased by -28.00% in one year.
Market Cap
465.89M
Enterprise Value
446.63M
Revenue
36.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.94
Market Cap Chart
Since March 1, 2005, BioPorto's market cap has increased from 75.28M to 465.89M, an increase of 518.88%. That is a compound annual growth rate of 9.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 454.50M | -10.00% |
| Dec 30, 2025 | 505.00M | -24.17% |
| Dec 30, 2024 | 665.97M | -16.07% |
| Dec 29, 2023 | 793.48M | 2.41% |
| Dec 30, 2022 | 774.78M | 17.16% |
| Dec 30, 2021 | 661.32M | -38.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.09T |
| Genmab | 110.28B |
| Coloplast | 104.48B |
| ALK-Abelló | 49.41B |
| ChemoMetec | 7.46B |
| Gubra | 6.46B |
| Pharma Equity Group | 119.56M |
| ViroGates | 111.38M |